We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+23.37%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$14M
(+14%)
Cap. Flow
-$1.47M
Cap. Flow
% of AUM
-1.3%
Top 10 Holdings %
Top 10 Hldgs %
43.47%
Holding
88
New
5
Increased
13
Reduced
43
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lucid Diagnostics
LUCD
|
+$1.23M |
| 2 |
Butterfly Network
BFLY
|
+$1.07M |
| 3 |
Zeta Global
ZETA
|
+$1.03M |
| 4 |
SKYT
SkyWater Technology
SKYT
|
+$911K |
| 5 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$566K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ondas Inc
ONDS
|
+$2.24M |
| 2 |
Exagen
XGN
|
+$1.88M |
| 3 |
Vericel Corp
VCEL
|
+$497K |
| 4 |
Sera Prognostics
SERA
|
+$363K |
| 5 |
Eli Lilly
LLY
|
+$320K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.9% |
| 2 | Technology | 26.28% |
| 3 | Communication Services | 7.77% |
| 4 | Industrials | 4.53% |
| 5 | Consumer Staples | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CVRx
CVRX
$158M
| $159K | 0.14% |
19,750
+3,400
| +21% | +$25.6K |
|
77
Airgain
AIRG
$70.9M
| $158K | 0.14% |
36,500
| – | – |
|
78
Accuray
ARAY
$33.2M
| $118K | 0.1% |
70,800
+800
| +1% | +$1.18K |
|
79
Rockwell Medical
RMTI
$28.6M
| $86.3K | 0.08% |
7,192
| – | – |
|
80
Puma Biotechnology
PBYI
$408M
| $64.8K | 0.06% |
+12,200
| New | +$51.7K |
|
|
FPAY
81
DELISTED
FlexShopper
FPAY
| $58K | 0.05% |
90,550
-95,000
| -51% | -$82.2K |
|
82
IRIDEX
IRIX
$14.5M
| $47.1K | 0.04% |
41,300
-6,000
| -13% | -$7.38K |
|
83
Pulmonx
LUNG
$91.1M
| $34K | 0.03% |
21,000
+11,000
| +110% | +$23K |
|
84
Baxter International
BAX
$14.3B
| – | – |
-6,900
| Closed | -$209K |
|
85
Myomo
MYO
$47.9M
| – | – |
-61,400
| Closed | -$133K |
|
|
SCPH
86
DELISTED
scPharmaceuticals
SCPH
| – | – |
-13,500
| Closed | -$51.4K |
|
87
Senseonics Holdings Inc
SENS
$271M
| – | – |
-4,000
| Closed | -$38.1K |
|
|
88
Sera Prognostics
SERA
$77.9M
| – | – |
-131,000
| Closed | -$363K |
|
Similar funds
PWP
BF
HWMG
WT
BAM
WLG
PA
STFP
Perkins Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Perkins Capital Management held 88 positions worth $113M, up 14% from $99.5M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Perkins Capital Management's Q3 2025 filing shows 5 new, 13 increased, 43 reduced and 5 closed positions. Its largest new stake was Lucid Diagnostics: 1,127,000 shares worth $1.14M. The largest sale was Ondas Inc, an estimated $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2025 buy was Lucid Diagnostics: 1,127,000 shares worth $1.14M.
- Perkins Capital Management added most to Butterfly Network in Q3 2025, an estimated $1.07M increase.
- Perkins Capital Management's biggest Q3 2025 reduction was Ondas Inc, cutting an estimated $2.24M.
- Perkins Capital Management fully exited Sera Prognostics in Q3 2025, selling an estimated $363K.
- Perkins Capital Management's ten largest holdings make up 43% of its $113M portfolio in Q3 2025.
- Perkins Capital Management opened 5 new positions and closed 5 in Q3 2025.
- Perkins Capital Management's portfolio value rose 14% quarter-over-quarter to $113M.
Based on Perkins Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.